| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.3 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as problematic, has been found in Apple macOS. This issue affects some unknown processing of the component Printing. Performing a manipulation results in an unknown weakness. This vulnerability is cataloged as CVE-2022-42862. The attack must be initiated from a local position. There is no exploit available. It is advisable to upgrade the affected component.
Details
A vulnerability, which was classified as problematic, was found in Apple macOS (Operating System). This affects an unknown functionality of the component Printing. This is going to have an impact on confidentiality, integrity, and availability.
The weakness was shared 12/13/2022 by Mickey Jin as HT213532 as confirmed advisory (Website). The advisory is shared at support.apple.com. This vulnerability is uniquely identified as CVE-2022-42862. Neither technical details nor an exploit are publicly available. The advisory points out:
An app may be able to bypass Privacy preferences
Upgrading to version 13.1 eliminates this vulnerability. A possible mitigation has been published immediately after the disclosure of the vulnerability. The advisory contains the following remark:
This issue was addressed by removing the vulnerable code.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Vendor
Name
Version
- 5.3
- 5.11
- 10.8.5
- 10.9.5
- 10.10
- 10.10.1
- 10.10.2
- 10.10.3
- 10.12
- 10.12.0
- 10.12.1
- 10.12.2
- 10.12.3
- 10.12.4
- 10.12.5
- 10.12.6
- 10.13
- 10.13.0
- 10.13.1
- 10.13.2
- 10.13.3
- 10.13.4
- 10.13.5
- 10.13.5 2018-003
- 10.13.6
- 10.14
- 10.14.1
- 10.14.2
- 10.14.4
- 10.14.5
- 10.14.6
- 10.15
- 10.15.0
- 10.15.1
- 10.15.2
- 10.15.3
- 10.15.4
- 10.15.5
- 10.15.6
- 10.15.7
- 11.0.1
- 11.1
- 11.2
- 11.2.1
- 11.2.3
- 11.3
- 11.3.1
- 11.4
- 11.5
- 11.6
- 11.6.6
- 11.7
- 11.7.3
- 11.7.5
- 11.7.9
- 12.0.1
- 12.1
- 12.2
- 12.2.1
- 12.3
- 12.3.1
- 12.4
- 12.5
- 12.5.1
- 12.6
- 12.6.2
- 12.6.3
- 12.6.4
- 12.6.7
- 12.6.8
- 12.7
- 12.7.1
- 12.7.5
- 12.7.6
- 13
- 13.0
License
Website
- Vendor: https://www.apple.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.4VulDB Meta Temp Score: 5.3
VulDB Base Score: 5.3
VulDB Temp Score: 5.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.5
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Local Privilege EscalationCWE: Unknown
CAPEC: 🔍
ATT&CK: 🔍
Physical: Partially
Local: Yes
Remote: Partially
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Upgrade: macOS 13.1
Timeline
10/11/2022 🔍12/13/2022 🔍
12/13/2022 🔍
12/14/2022 🔍
04/22/2025 🔍
Sources
Vendor: apple.comAdvisory: HT213532
Researcher: Mickey Jin
Status: Confirmed
CVE: CVE-2022-42862 (🔍)
GCVE (CVE): GCVE-0-2022-42862
GCVE (VulDB): GCVE-100-215769
scip Labs: https://www.scip.ch/en/?labs.20180712
Entry
Created: 12/14/2022 11:44Updated: 04/22/2025 01:50
Changes: 12/14/2022 11:44 (17), 12/14/2022 11:47 (28), 01/12/2023 09:33 (2), 01/12/2023 09:36 (11), 04/22/2025 01:50 (16)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.

No comments yet. Languages: en.
Please log in to comment.